UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers

Clinical cancer research, 2008-10, Vol.14 (20), p.6456-6468

2008

Volltextzugriff (PDF)

Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma

PloS one, 2016-09, Vol.11 (9), p.e0159749-e0159749

2016

Volltextzugriff (PDF)

A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo

PloS one, 2015-08, Vol.10 (8), p.e0133892-e0133892

2015

Volltextzugriff (PDF)

Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance

Genome medicine, 2018-07, Vol.10 (1), p.55-55, Article 55

2018

Volltextzugriff (PDF)

CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus

Cancers, 2021-03, Vol.13 (5), p.1050

2021

Volltextzugriff (PDF)

Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors

Translational oncology, 2020-02, Vol.13 (2), p.221-232

2020

Volltextzugriff (PDF)

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma

Journal of Immunology Research, 2017-01, Vol.2017 (2017), p.1-13

2017

Volltextzugriff (PDF)

GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway

Scientific reports, 2018-04, Vol.8 (1), p.5750-14, Article 5750

2018

Volltextzugriff (PDF)

Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers

Journal of Oncology, 2009-01, Vol.2009 (2009), p.479-484

2009

Volltextzugriff (PDF)

Overview of viscumTT

Phytomedicine (Stuttgart), 2019, Vol.61, p.5-5

2019

Volltextzugriff (PDF)

Investigation of cell culture volatilomes using solid phase micro extraction: Options and pitfalls exemplified with adenocarcinoma cell lines

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2015-12, Vol.1006, p.158-166

2015

Volltextzugriff (PDF)

Abstract A006: Preclinical models from rare aggressive tumors: Establishment, drug sensitivity and genomic analyses of mesothelioma PDX as models for oncology drug development

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.A006-A006

2019

Volltextzugriff (PDF)

QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experiments

Nucleic acids research, 2017-04, Vol.45 (6), p.e44-e44

2017

Volltextzugriff (PDF)

Abstract A014: Gastric cancer PDX models for predictive preclinical studies: Establishment, drug sensitivity, and genomic characterization

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.A014-A014

2019

Volltextzugriff (PDF)

Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?

European journal of cardio-thoracic surgery, 2009-09, Vol.36 (3), p.454-459

2009

Volltextzugriff (PDF)

Abstract A02: Patient-derived xenograft models of neuroblastoma as improvement for the prediction of targeted therapies for childhood cancer

Cancer research (Chicago, Ill.), 2020-06, Vol.80 (11_Supplement), p.A02-A02

2020

Volltextzugriff (PDF)

Retraction

Science signaling, 2021-11, Vol.14 (708)

2021

Volltextzugriff (PDF)

Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?

European journal of cardio-thoracic surgery, 2011-07, Vol.40 (1), p.e29-e33

2011

Volltextzugriff (PDF)

Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non-Small Cell Lung Cancer

Clinical cancer research, 2010-03, Vol.16 (5), p.1452-1465

2010

Volltextzugriff (PDF)

Abstract 3225: Identification of predictive drug resistance markers in preclinical xenograft models (PDX) of soft tissue sarcomas

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3225-3225

2015

Volltextzugriff (PDF)

Predictive In Vivo Models for Oncology

Handbook of experimental pharmacology, 2016, Vol.232, p.203-221

2016

Volltextzugriff (PDF)

Charakterisierung von in-vivo-modellen des humanen nicht-kleinzelligen lungenkarzinoms zur therapieoptimierung

Rolff, Jana

2012

Volltextzugriff (PDF)

Whole mistletoe extract viscumTT has anti-cancer effects in osteosarcoma in vitro and in vivo

Phytomedicine (Stuttgart), 2015-11, Vol.22, p.S11-S12

2015

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(18)
Humans
(16)
Animals
(15)
Mice
(10)
Oncology
(9)
Female
(7)
Lung Cancer
(7)
Lung Neoplasms - Metabolism
(7)
Lung Neoplasms - Pathology
(7)
Tumors
(7)
Apoptosis
(6)
Cancer Therapies
(6)
Male
(6)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Carcinoma, Non-Small-Cell Lung - Metabolism
(5)
Carcinoma, Non-Small-Cell Lung - Pathology
(5)
Cell Line, Tumor
(5)
Lung Neoplasms - Drug Therapy
(5)
Lung Neoplasms - Genetics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers

Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma

A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo

Therapeutic targeting of ATR in alveolar rhabdomyosarcoma

Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance

CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus

Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma

GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway

Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers

Overview of viscumTT

Investigation of cell culture volatilomes using solid phase micro extraction: Options and pitfalls exemplified with adenocarcinoma cell lines

Abstract A006: Preclinical models from rare aggressive tumors: Establishment, drug sensitivity and genomic analyses of mesothelioma PDX as models for oncology drug development

QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experiments

Abstract A014: Gastric cancer PDX models for predictive preclinical studies: Establishment, drug sensitivity, and genomic characterization

Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?

Abstract A02: Patient-derived xenograft models of neuroblastoma as improvement for the prediction of targeted therapies for childhood cancer

Influence of eukaryotic translation initiation factor 6 on non–small cell lung cancer development and progression

Retraction

Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?

Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non-Small Cell Lung Cancer

Abstract 3225: Identification of predictive drug resistance markers in preclinical xenograft models (PDX) of soft tissue sarcomas

Predictive In Vivo Models for Oncology

Charakterisierung von in-vivo-modellen des humanen nicht-kleinzelligen lungenkarzinoms zur therapieoptimierung

Whole mistletoe extract viscumTT has anti-cancer effects in osteosarcoma in vitro and in vivo

Suchergebnisse filtern